CD30-targeting antibody-drug conjugate

This page covers all CD30-targeting antibody-drug conjugate drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CD30.

Targets

CD30

Phase 2 pipeline (2)

• ABVD and Radiotherapy · Fondazione Italiana Linfomi - ETS · Oncology
  Brentuximab vedotin targets CD30
• Consolidation with Brentuximab Vedotin · Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea · Oncology
  Antibody-drug conjugate targeting CD30